These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
218 related articles for article (PubMed ID: 8475126)
1. Efficient transplantation of BCR-ABL-induced chronic myelogenous leukemia-like syndrome in mice. Gishizky ML; Johnson-White J; Witte ON Proc Natl Acad Sci U S A; 1993 Apr; 90(8):3755-9. PubMed ID: 8475126 [TBL] [Abstract][Full Text] [Related]
2. Efficient and rapid induction of a chronic myelogenous leukemia-like myeloproliferative disease in mice receiving P210 bcr/abl-transduced bone marrow. Pear WS; Miller JP; Xu L; Pui JC; Soffer B; Quackenbush RC; Pendergast AM; Bronson R; Aster JC; Scott ML; Baltimore D Blood; 1998 Nov; 92(10):3780-92. PubMed ID: 9808572 [TBL] [Abstract][Full Text] [Related]
3. Bcr-Abl efficiently induces a myeloproliferative disease and production of excess interleukin-3 and granulocyte-macrophage colony-stimulating factor in mice: a novel model for chronic myelogenous leukemia. Zhang X; Ren R Blood; 1998 Nov; 92(10):3829-40. PubMed ID: 9808576 [TBL] [Abstract][Full Text] [Related]
4. The P190, P210, and P230 forms of the BCR/ABL oncogene induce a similar chronic myeloid leukemia-like syndrome in mice but have different lymphoid leukemogenic activity. Li S; Ilaria RL; Million RP; Daley GQ; Van Etten RA J Exp Med; 1999 May; 189(9):1399-412. PubMed ID: 10224280 [TBL] [Abstract][Full Text] [Related]
5. Bcr-Abl has a greater intrinsic capacity than v-Abl to induce the neoplastic expansion of myeloid cells. Gross AW; Ren R Oncogene; 2000 Dec; 19(54):6286-96. PubMed ID: 11175343 [TBL] [Abstract][Full Text] [Related]
6. Disease progression in a murine model of bcr/abl leukemogenesis. van Etten RA Leuk Lymphoma; 1993; 11 Suppl 1():239-42. PubMed ID: 8251903 [TBL] [Abstract][Full Text] [Related]
7. Role of SPA-1 in phenotypes of chronic myelogenous leukemia induced by BCR-ABL-expressing hematopoietic progenitors in a mouse model. Kometani K; Aoki M; Kawamata S; Shinozuka Y; Era T; Taniwaki M; Hattori M; Minato N Cancer Res; 2006 Oct; 66(20):9967-76. PubMed ID: 17047059 [TBL] [Abstract][Full Text] [Related]
8. Blast crisis in a murine model of chronic myelogenous leukemia. Daley GQ; Van Etten RA; Baltimore D Proc Natl Acad Sci U S A; 1991 Dec; 88(24):11335-8. PubMed ID: 1763047 [TBL] [Abstract][Full Text] [Related]
9. Inducible chronic phase of myeloid leukemia with expansion of hematopoietic stem cells in a transgenic model of BCR-ABL leukemogenesis. Koschmieder S; Göttgens B; Zhang P; Iwasaki-Arai J; Akashi K; Kutok JL; Dayaram T; Geary K; Green AR; Tenen DG; Huettner CS Blood; 2005 Jan; 105(1):324-34. PubMed ID: 15331442 [TBL] [Abstract][Full Text] [Related]
10. v-abl causes hematopoietic disease distinct from that caused by bcr-abl. Scott ML; Van Etten RA; Daley GQ; Baltimore D Proc Natl Acad Sci U S A; 1991 Aug; 88(15):6506-10. PubMed ID: 1862078 [TBL] [Abstract][Full Text] [Related]
11. Expression of interferon consensus sequence binding protein (ICSBP) is downregulated in Bcr-Abl-induced murine chronic myelogenous leukemia-like disease, and forced coexpression of ICSBP inhibits Bcr-Abl-induced myeloproliferative disorder. Hao SX; Ren R Mol Cell Biol; 2000 Feb; 20(4):1149-61. PubMed ID: 10648600 [TBL] [Abstract][Full Text] [Related]
13. Induction of a chronic myelogenous leukemia-like syndrome in mice with v-abl and BCR/ABL. Kelliher MA; McLaughlin J; Witte ON; Rosenberg N Proc Natl Acad Sci U S A; 1990 Sep; 87(17):6649-53. PubMed ID: 2204061 [TBL] [Abstract][Full Text] [Related]
14. The src homology 2 domain of Bcr/Abl is required for efficient induction of chronic myeloid leukemia-like disease in mice but not for lymphoid leukemogenesis or activation of phosphatidylinositol 3-kinase. Roumiantsev S; de Aos IE; Varticovski L; Ilaria RL; Van Etten RA Blood; 2001 Jan; 97(1):4-13. PubMed ID: 11133737 [TBL] [Abstract][Full Text] [Related]
15. The Tel-Abl (ETV6-Abl) tyrosine kinase, product of complex (9;12) translocations in human leukemia, induces distinct myeloproliferative disease in mice. Million RP; Aster J; Gilliland DG; Van Etten RA Blood; 2002 Jun; 99(12):4568-77. PubMed ID: 12036890 [TBL] [Abstract][Full Text] [Related]
16. Hematologic disease induced in BALB/c mice by a bcr-abl retrovirus is influenced by the infection conditions. Elefanty AG; Cory S Mol Cell Biol; 1992 Apr; 12(4):1755-63. PubMed ID: 1312670 [TBL] [Abstract][Full Text] [Related]
17. Fyn is not essential for Bcr-Abl-induced leukemogenesis in mouse bone marrow transplantation models. Doki N; Kitaura J; Uchida T; Inoue D; Kagiyama Y; Togami K; Isobe M; Ito S; Maehara A; Izawa K; Kato N; Oki T; Harada Y; Nakahara F; Harada H; Kitamura T Int J Hematol; 2012 Feb; 95(2):167-75. PubMed ID: 22189847 [TBL] [Abstract][Full Text] [Related]